The purpose of this study is to tailor existing sexual assault nurse examiner (SANE) services with same-day HIV prophylaxis and substance use screening, brief intervention, or referral using semi-structured adolescents and young adults (AYA) survivor and key informant interviews, and iterative co-design/pilot testing of adapted strategies with the youth working group (YWG), to optimize study mechanisms and outcome measures using cognitive interviews, analysis of community partner data, and recruitment and retention strategies with the youth working group (YWG) and community advisory board (CAB), to conduct a pilot randomized controlled trial with 40 AYA to test feasibility, acceptability, and initial efficacy compared to usual care, to evaluate recruitment, randomization, and follow-up strategies; adherence to intervention dose; retention benchmarks; and acceptability and to evaluate preliminary efficacy of outcome measures (uptake of post-assault HIV prevention and substance use treatment).
Age range
17 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Recruitment feasibility as measured by percentage of eligible individuals screened
Timeframe: end of study (1 month after baseline)
Recruitment feasibility as measured by percentage of eligible individuals enrolled
Timeframe: end of study (1 month after baseline)
Recruitment feasibility as measured by time delay from screening to enrollment
Timeframe: end of study (1 month after baseline)
Recruitment feasibility as measured by time to enroll sufficient sample size
Timeframe: end of study (1 month after baseline)
Recruitment feasibility as measured by percentage loss to exclusion criteria.
Timeframe: end of study (1 month after baseline)
Randomization strategies as measured by proportion randomized to intervention and control
Timeframe: end of study (1 month after baseline)
Retention as measured by the number of participants that completed the one month follow-up survey
Diane M Santa Maria, DrPH,MSN,FAANRN,PHNA-BC,FSAHM
Timeframe: end of study (1 month after baseline)
Retention of the intervention group as measured by the number of participants that completed the one month follow-up survey
Timeframe: end of study (1 month after baseline)
Retention of the control group as measured by the number of participants that completed the one month follow-up survey
Timeframe: end of study (1 month after baseline)
Adherence to intervention as measured by percentage of content completed in the fidelity checklist
Timeframe: end of study (1 month after baseline)
Acceptability as measured by percentage of data loss
Timeframe: end of study (1 month after baseline)
Acceptability as measured by score on the credibility/expectancy questionnaire
Timeframe: end of study (1 month after baseline)
Acceptability as measured by score on the credibility/expectancy questionnaire
Timeframe: end of study (1 month after baseline)